Company Filing History:
2 out of 622 
1 out of 16 
1 out of 832,891 Years Active: 2014-2023
Title: Trai-Ming Yeh: Innovator in Dengue Vaccine Development
Introduction
Trai-Ming Yeh is a prominent inventor based in Tainan, Taiwan. He has made significant contributions to the field of vaccine development, particularly in combating dengue virus infections. With a total of 3 patents to his name, Yeh's work is pivotal in enhancing public health.
Latest Patents
Yeh's latest patents include a composition of a subunit dengue vaccine. This invention relates to a fusion protein that connects delta C nonstructural protein 1 (NS1) to polypeptides of NS3c and/or consensus envelope protein domain III (cEDIII). This innovative approach aims to provide better protection against dengue virus challenges and alleviate associated pathological effects. Another notable patent is for an anti-dengue virus antibody, which includes a pharmaceutical composition and its various uses. This antibody comprises specific amino acid sequences that enhance its efficacy against the dengue virus.
Career Highlights
Throughout his career, Trai-Ming Yeh has worked with esteemed institutions such as National Cheng Kung University and DCB-USA LLC. His research and innovations have garnered attention in the scientific community, contributing to advancements in vaccine technology.
Collaborations
Yeh has collaborated with notable colleagues, including Yung-Chun Chuang and Yee-Shin Lin. These partnerships have facilitated the development of groundbreaking solutions in the fight against dengue fever.
Conclusion
Trai-Ming Yeh's contributions to dengue vaccine development highlight his role as an influential inventor in the field. His innovative patents and collaborations continue to pave the way for advancements in public health.